Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03610022
Title Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 (OPTIVISMO-1)
Acronym OPTIVISMO-1
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors University Hospital, Bordeaux
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.